Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2021-09-29 00:00:00 ET · period of report 2021-09-27 · accession 0001209191-21-058071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-29 | 2021-09-27 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $0.86 | +5,000 | 109.3K | +5% | +$4,300 |
| D | 2021-09-29 | 2021-09-27 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $0.00 | -5,000 | 18.8K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-27 | M | A | 5,000 | $0.86 | 109,277 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2021-09-27 | M | D | 5,000 | $0.00 | 18,833 | D | $0.86 · — to 2027-03-09 | 5,000 Common Stock | (F1) 1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. |